What criteria are used in Switzerland to approve and reimburse therapies and medical services? Who makes these decisions, and how can patients bring their perspectives into these processes?
Our new course format, with an EUPATI Switzerland online course on 15 October 2026, addresses exactly these questions. In a compact afternoon format, experts from patient advocacy, industry and public authorities will provide practical insights into the fundamentals of the approval of new therapies, Health Technology Assessment (HTA) and health policy processes in Switzerland.
We are very pleased to welcome our speakers: Dr. med. Ramiro Gilardino, MSc Gurmit Sandhu, Dr. iur. Angelina Rau, Dr. Stephanie Vollenweider and David Haerry
The course programme and registration form can be found in the course announcement.
📅 Thursday, 15 October 2026
🕑 14:00–17:00
💻 Online
🌐 Course language: English
The course is aimed at patients, Patient Experts, representatives of patient organisations and engaged individuals with lived experience. Participation is free of charge. Participants can complete a short test after the course to receive a course certificate.
Date posted: August 17, 2026
Categories: Uncategorized
